You are here

  • Home
  • Archive
  • Volume 13, Issue e1
  • Addition of aprepitant improves acute emesis control in children and adolescents receiving induction chemotherapy for acute myeloid leukaemia: a randomised, open-label trial

Article metrics

Article menu
Download PDFPDF
Original research
Addition of aprepitant improves acute emesis control in children and adolescents receiving induction chemotherapy for acute myeloid leukaemia: a randomised, open-label trial

 

Online download statistics by month:

Online download statistics by month: October 2020 to September 2024

AbstractFullPdf
Oct 202014230
Nov 20202962114
Dec 202013492
Jan 202113845
Feb 20218544
Mar 202119011
Apr 20218920
May 20212700
Jun 2021100
Jul 2021212
Aug 2021533
Sep 2021531
Oct 20218110
Nov 202112420
Dec 202115230
Jan 202210401
Feb 202210821
Mar 202219134
Apr 202211601
May 20229600
Jun 20228410
Jul 20228244
Aug 202210622
Sep 20228011
Oct 202211520
Nov 202212275
Dec 202211511
Jan 202311211
Feb 20237801
Mar 202310300
Apr 20239701
May 202310210
Jun 20236800
Jul 20237700
Aug 202313000
Sep 20237400
Oct 202319367
Nov 202327586
Dec 202325122
Jan 202411131
Feb 20249700
Mar 20249741
Apr 202413521
May 20247000
Jun 202410011
Jul 20248732
Aug 202411710
Sep 20244501
Total520911277